Literature DB >> 12207332

CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.

Tatjana Samardzic1, Judith Gerlach, Kerstin Muller, Dragan Marinkovic, Jochen Hess, Lars Nitschke, Thomas Wirth.   

Abstract

BOB.1/OBF.1 (also called OCA-B), a B lymphocyte-specific transcriptional coactivator, is recruited to octamer-containing promoters by interacting with the Oct-1 or Oct-2 proteins. BOB.1/OBF.1-deficient mice show impaired secondary immunoglobulin isotype secretion and complete absence of germinal centers. Furthermore, numbers of splenic B cells are reduced due to a developmental block at the transitional B cell stage in the bone marrow. We found that surface expression of CD22 is selectively increased on B lineage cells in the bone marrow of BOB.1/OBF.1-deficient mice. CD22 is known as a negative regulator of B cell receptor signaling. We therefore investigated whether defects in B cell development in the BOB.1/OBF.1-deficient mice might be due to CD22 up-regulation. Mice were generated lacking both genes. In BOB.1/OBF.1xCD22 double-deficient mice, numbers of transitional B cells in the bone marrow were normal. Consequently, double-deficient mice also had normal B to T cell ratios in the spleen. We show that BOB.1/OBF.1(-/-) B cells were incapable to induce BCR-triggered Ca(2+) mobilization. This Ca(2+)-signalling defect was restored in BOB.1/OBF.1xCD22 double-deficient B cells. Nevertheless, double-deficient animals were unable to mount humoral immune responses and to form germinal centers. Finally, we demonstrate that CD22(-/-) splenic B cells proliferate independently of BOB.1/OBF.1 upon stimulation with LPS. These studies suggest that the B cell differentiation defect observed in BOB.1/OBF.1(-/-) mice is BCR-signal dependent. However, the impairment in germinal center formation is caused by a different mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207332     DOI: 10.1002/1521-4141(200209)32:9<2481::AID-IMMU2481>3.0.CO;2-C

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses.

Authors:  Sreemanti Basu; Avijit Ray; Bonnie N Dittel
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

2.  The Ets factor Spi-B is a direct critical target of the coactivator OBF-1.

Authors:  Boris Bartholdy; Camille Du Roure; Alain Bordon; Dianne Emslie; Lynn M Corcoran; Patrick Matthias
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-21       Impact factor: 11.205

3.  T Cell Specific BOB.1/OBF.1 Expression Promotes Germinal Center Response and T Helper Cell Differentiation.

Authors:  Annika C Betzler; Jasmin Ezić; Tsima Abou Kors; Thomas K Hoffmann; Thomas Wirth; Cornelia Brunner
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

Review 4.  Calcium signalling and cell-fate choice in B cells.

Authors:  Andrew M Scharenberg; Lisa A Humphries; David J Rawlings
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

5.  Homeodomain-interacting protein kinase (HIPK)-1 is required for splenic B cell homeostasis and optimal T-independent type 2 humoral response.

Authors:  Fiona M Guerra; Jennifer L Gommerman; Steven A Corfe; Christopher J Paige; Robert Rottapel
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

6.  Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response.

Authors:  Lynn Corcoran; Dianne Emslie; Tobias Kratina; Wei Shi; Susanne Hirsch; Nadine Taubenheim; Stephane Chevrier
Journal:  Front Immunol       Date:  2014-03-20       Impact factor: 7.561

7.  Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus.

Authors:  Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

8.  B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1.

Authors:  Alex Karnowski; Stephane Chevrier; Gabrielle T Belz; Adele Mount; Dianne Emslie; Kathy D'Costa; David M Tarlinton; Axel Kallies; Lynn M Corcoran
Journal:  J Exp Med       Date:  2012-10-08       Impact factor: 14.307

9.  B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice.

Authors:  Cornelia Brunner; Dragan Marinkovic; Jörg Klein; Tatjana Samardzic; Lars Nitschke; Thomas Wirth
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

10.  Silencing and nuclear repositioning of the lambda5 gene locus at the pre-B cell stage requires Aiolos and OBF-1.

Authors:  Alexander Karnowski; Chun Cao; Gabriele Matthias; Sebastian Carotta; Lynn M Corcoran; Inga-Lill Martensson; Jane A Skok; Patrick Matthias
Journal:  PLoS One       Date:  2008-10-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.